SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-26-003677 to VERU INC. (VERU)

VERU INC.
Date: April 13, 2026 · CIK: 0000863894 · Accession: 0000000000-26-003677

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-294911

Date
April 13, 2026
Author
Division of
Form
UPLOAD
Company
VERU INC.

Letter

Re: Veru Inc. Registration Statement on Form S-3 Filed April 7, 2026 File No. 333-294911 Dear Mitchell Steiner:

April 13, 2026

Mitchell Steiner Chief Executive Officer Veru Inc. 2916 N. Miami Avenue Suite 1000 Miami, FL 33127

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Lauren Hamill at 303-844-1008 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Benjamin Lombard

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 April 13, 2026

Mitchell Steiner
Chief Executive Officer
Veru Inc.
2916 N. Miami Avenue
Suite 1000
Miami, FL 33127

 Re: Veru Inc.
 Registration Statement on Form S-3
 Filed April 7, 2026
 File No. 333-294911
Dear Mitchell Steiner:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Lauren Hamill at 303-844-1008 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Benjamin Lombard
</TEXT>
</DOCUMENT>